Chlorohydrin-Arglabin regulatory update

NLAB's Paracure Inc. subsidiary received U.S. Patent No. 6,020,365 covering the use of a chlorohydrin derivative of the company's Arglabin plant-derived inhibitor of farnesyl transferase to treat var...